Navigation Links
Some Severe MS Flares Helped by Blood Filtering Treatment
Date:1/17/2011

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Jan. 17 (HealthDay News) -- A blood-filtering procedure called plasma exchange helps ease severe flares of multiple sclerosis (MS), but does not help with more advanced, progressive forms of the disease, new guidelines say.

Plasma exchange, or plasmapheresis, is also effective in treating severe forms of Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy and it may be considered to treat some other kinds of inflammatory neuropathies, according to the American Academy of Neurology guidelines.

Periodically, the academy reviews the available research on various procedures, ranks the evidence according to quality of the research and issues new recommendations that many neurologists use in their practice.

The updated guidelines, based on a review of research published between 1995 and 2009, are published in the Jan. 18 issue of Neurology. The previous guidelines were issued in 1996.

"With multiple sclerosis, plasmapheresis works, but only with the acute attacks, and it should also be used only when steroids do not work," said guidelines co-author Dr. Vinay Chaudhry, a professor of neurology at Johns Hopkins University School of Medicine. "If the MS is chronic or progressive, not the relapsing or remitting type, plasmapheresis does not work."

In plasma exchange, developed in the 1970s, a patient's blood is removed from the body and filtered. The patient's blood and platelets are returned, but the plasma is replaced with donor plasma.

Though physicians aren't entirely sure why plasma exchange works, it's generally believed that filtering removes harmful proteins and antibodies in the plasma that attack the central nervous system.

Multiple sclerosis is an autoimmune disease in which the body's own immune system attacks myelin, or the sheath that insulates nerve fibers of the central nervous system. The damage disrupts nerve signals traveling to and from the brain, which can lead to numbness, movement difficulties, blurred vision, fatigue and cognitive issues.

About 85 percent of those with MS start with a relapsing-remitting course, in which attacks are followed by partial or total recovery. Eventually, more than half go on to develop a more progressive form of the disease with fewer and shorter symptomless periods.

At the outset of the disease, doctors usually treat MS flares with steroids, said Dr. Lily Jung, medical director of the neurology clinic at the Swedish Neuroscience Institute in Seattle.

According to the guidelines, if the attack is particularly severe and the steroids are not helping, doctors should consider using plasma exchange.

However, the treatment is not effective for more advanced and aggressive forms of the disease, including chronic or secondary progressive forms, the guidelines say.

Researchers also looked at the evidence for the use of plasma exchange for other neurologic disorders, including myasthenia gravis and pediatric autoimmune neuropsychiatric disorders associated with streptococcus infection, but there was not enough evidence to determine whether it is an effective treatment.

The recommendations make sense, Jung said. Plasmapheresis can be grueling and generally requires a hospital stay of about 10 days. Complications can include infection and blood clots, so it should be reserved for patients with a severe flare, which may include an inability to walk and the possibility of months of physical rehabilitation.

"In patients with relapsing disease who are not doing well with steroids, and their deficits are great enough to warrant it, this may not be a bad thing and might allow them to get out of the hospital sooner," Jung said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on multiple sclerosis.

SOURCES: Vinay Chaudhry, M.D., professor, neurology, Johns Hopkins University School of Medicine, Baltimore; Lily Jung, M.D. medical director, neurology clinic, Swedish Neuroscience Institute, Seattle; Jan. 18, 2011, Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Less invasive techniques help manage complications of severe pancreatic disease
2. Chronic Nasal Congestion May Be Linked to Severe Asthma
3. Cancer Patients Who Smoke Report More Severe Pain
4. Mount Sinai first in US to implant aortic valve prosthesis to treat severe aortic stenosis
5. Obesity increases risk of death in severe vehicle crashes, study shows
6. Nasal congestion can mean severe asthma
7. Severe Pain Can Trigger Suicide in Hospital ERs
8. Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada
9. Rare, Severe Form of Morning Sickness Appears to Be Genetic
10. Severe Acne May Up Suicide Risk: Study
11. A comparison of severe outcomes during the waves of pandemic (H1N1) 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Severe MS Flares Helped by Blood Filtering Treatment 
(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: